Rascol O - Search Results

1

Ferreira JJ, Neutel D, Mestre T, Coelho M, Rosa MM, Rascol O, Sampaio C. Ferreira JJ, et al. Among authors: rascol o. Mov Disord. 2010 Jan 30;25(2):139-48. doi: 10.1002/mds.22855. Mov Disord. 2010. PMID: 20063399 Free article. Review.

2

Treatment interventions for Parkinson's disease: an evidence based assessment.

Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Rascol O, et al. Lancet. 2002 May 4;359(9317):1589-98. doi: 10.1016/S0140-6736(02)08520-3. Lancet. 2002. PMID: 12047983 Review.

3

Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family.

Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Tsuboi Y, et al. Among authors: rascol o. Arch Neurol. 2002 Jun;59(6):943-50. doi: 10.1001/archneur.59.6.943. Arch Neurol. 2002. PMID: 12056930

4

The management of patients with early Parkinson's disease.

Rascol O, Brefel-Courbon C, Payoux P, Ferreira J. Rascol O, et al. Adv Neurol. 2003;91:203-11. Adv Neurol. 2003. PMID: 12442679 Review. No abstract available.

5

Deficit of verb generation in nondemented patients with Parkinson's disease.

Péran P, Rascol O, Démonet JF, Celsis P, Nespoulous JL, Dubois B, Cardebat D. Péran P, et al. Among authors: rascol o. Mov Disord. 2003 Feb;18(2):150-6. doi: 10.1002/mds.10306. Mov Disord. 2003. PMID: 12539207

6

Limitations of current Parkinson's disease therapy.

Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Rascol O, et al. Ann Neurol. 2003;53 Suppl 3:S3-12; discussion S12-5. doi: 10.1002/ana.10513. Ann Neurol. 2003. PMID: 12666094 Review.

7

Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.

Ziegler M, Castro-Caldas A, Del Signore S, Rascol O. Ziegler M, et al. Among authors: rascol o. Mov Disord. 2003 Apr;18(4):418-25. doi: 10.1002/mds.10359. Mov Disord. 2003. PMID: 12671949 Clinical Trial.

8

Levodopa in the treatment of Parkinson's disease: current controversies.

Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Olanow CW, et al. Among authors: rascol o. Mov Disord. 2004 Sep;19(9):997-1005. doi: 10.1002/mds.20243. Mov Disord. 2004. PMID: 15372588 Review.

9

Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study.

Zijlmans JC, Debilly B, Rascol O, Lees AJ, Durif F. Zijlmans JC, et al. Among authors: rascol o. Mov Disord. 2004 Sep;19(9):1006-1011. doi: 10.1002/mds.20188. Mov Disord. 2004. PMID: 15372589 Clinical Trial.

10

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Goetz CG, et al. Among authors: rascol o. Mov Disord. 2004 Sep;19(9):1020-8. doi: 10.1002/mds.20213. Mov Disord. 2004. PMID: 15372591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters